GEL-E
gel-e Life Sciences has developed an advanced wound care platform that can be used across a broad spectrum of clinical and non-clinical settings. By making molecular modifications to natural biopolymers, gel-e’s patented approach provides rapid hemostasis in a clean, safe healing environment. Using non-dilutive grant funding, the company has achieved milestones such as 1 FDA Clearance, 5 issued patents, and 6 peer-reviewed publications.
GEL-E
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2013-01-01
Address:
College Park, Maryland, United States
Country:
United States
Website Url:
http://www.gel-e.co
Total Employee:
11+
Status:
Active
Contact:
301) 405-3585
Email Addresses:
[email protected]
Total Funding:
4.08 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Apache Wordpress Plugins Google Maps PHP PHP 7
Current Advisors List
Current Employees Featured
Founder
Investors List
New York Angels
New York Angels investment in Seed Round - Gel-E
Robin Hood Ventures
Robin Hood Ventures investment in Seed Round - Gel-E
Dingman Center for Entrepreneurship
Dingman Center for Entrepreneurship investment in Seed Round - Gel-E
National Science Foundation
National Science Foundation investment in Grant - Gel-E
Official Site Inspections
http://www.gel-e.co
- Host name: nl1-sr1.supercp.com
- IP address: 68.66.248.7
- Location: Ann Arbor United States
- Latitude: 42.2503
- Longitude: -83.8393
- Metro Code: 505
- Timezone: America/Detroit
- Postal: 48106
More informations about "Gel-E"
Gel-e, Inc. changes its name to Medcura … a name befitting the …
Gel-e, Inc. changes its name to Medcura … a name befitting the company poised to disrupt consumer, clinical and military markets ... andScaled cGMP manufacture has been put in …See details»
Gel-E - Crunchbase Company Profile & Funding
Gel-e Life Sciences has developed an advanced wound care platform that can be used across a broad spectrum of clinical and non-clinical settings. By making molecular modifications to …See details»
gel-e, Inc. changes its name to Medcura - BioSpace
Dec 19, 2019 gel-e, Inc., announced today that the Company has changed its name to Medcura. gel-e, Inc., announced today that the Company has changed its name to Medcura. ... The …See details»
gel-e, Inc. changes its name to Medcura - PR Newswire
COLLEGE PARK, Md., Dec. 19, 2019 /PRNewswire/ -- gel-e, Inc., announced today that the Company has changed its name to Medcura.The corporate name change is effective …See details»
Gel-E, Inc. - TEDCO
Jul 20, 2016 TEDCO portfolio company gel-e receives Breakthrough Device Designation from FDA June 18, 2019 TEDCO portfolio company gel-e Receives $1.4M DoD Grant to Develop …See details»
gel-e, Inc. changes its name to Medcura - Markets Insider
COLLEGE PARK, Md., Dec. 19, 2019 /PRNewswire/ -- gel-e, Inc., announced today that the Company has changed its name to Medcura. The corporate name...See details»
Gel-E: Drug pipelines, Patents, Clinical trials - Synapse
Jul 14, 2023 Last update 31 May 2023. Gel-E. Private Company |See details»
Gel-E - Funding, Financials, Valuation & Investors - Crunchbase
Gel-E is funded by 4 investors. New York Angels and Robin Hood Ventures are the most recent investors. Gel-E has a post-money valuation in the range of $1M to $10M as of Jul 14, 2017, …See details»
Gel-E - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Developed an advanced wound care platform designed to be used across a broad spectrum of clinical.See details»
gel-e Secures $3.1 Million Financing for Innovative Hemostatic and ...
COLLEGE PARK, Md., July 13, 2017 /PRNewswire/ -- gel-e Inc., a privately-held, clinical-stage medical device company, today announces that it has raised $3.1 million in a private financing, …See details»
gel-e | VentureRadar
Gel-e VentureRadar profile. Find out more about gel-e, Biotechnology.See details»
gel-e, Inc Secures $3.1 Million Financing For Innovative ... - BioSpace
Jul 13, 2017 The financing allows gel-e to expand its initial U.S. FDA regulatory clearance for the management of bleeding wounds, including vascular access sites (Vascular gel-e ®) to a …See details»
Breakthrough Device Designation received from the FDA - PR …
GAITHERSBURG, Md., June 18, 2019 /PRNewswire/ -- gel-e Inc., announces Breakthrough Status Designation from the U.S. Food and Drug Administration (FDA) for its first internal-use …See details»
Gel-E - Crunchbase
Developed an advanced wound care platform designed to be used across a broad spectrum of clinical.See details»
gel-e Announces $3.1 Million in Private Financing
Aug 9, 2017 “gel-e exemplifies an ideal investment for us,” said Jim Hughes, Director, UM Ventures, a joint initiative of the University of Maryland, Baltimore and University of Maryland, …See details»
gel-e Expands Core Team with Regulatory ... - Markets Insider
COLLEGE PARK, Md., Sept. 13, 2017 /PRNewswire/ -- gel-e Inc., a privately held, clinical-stage medical device company, announces the recent expans... Menu icon A vertical stack of three …See details»
gel-e Expands its OTC Label - UM Ventures
Gel-e Inc., announces the 510(k) clearance of gel-e FLEX by the U.S. Food and Drug Administration (FDA) for the over-the-counter (OTC) use of its first flowable hemostat.This new …See details»
Gel-E - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Gel-E . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of Board …See details»
Biohealth Innovation - gel-e expands its OTC label
Jul 2, 2018 gel-e Inc., announces the 510(k) clearance of gel-e FLEX by the U.S. Food and Drug Administration (FDA) for the over-the-counter (OTC) use of its first flowable hemostat. This …See details»
Med Tech startup gel-e has developed revolutionary technology
Sep 11, 2017 Stephen Hawking had good reason to call gel-e “a top innovative product of this decade.” The Propel(x) alumnus company is poised to deploy a revolutionary technology to …See details»